Company Filing History:

12 out of 940

Fujisawa Pharmaceutical Company, Ltd.

Years Active: 1990-2007

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 7166598 - Piperazine derivatives (2007-01-23),

2. 6924278 - Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists (2005-08-02),

3. 6787543 - Benzhydryl derivatives (2004-09-07),

4. 6087357 - Piperazine derivatives as tachykinin antagonists (2000-07-11),

5. 5994378 - Thiazolylbenzofuran derivatives and pharmaceutical compositions (1999-11-30),

6. 5939413 - Piperazine derivatives (1999-08-17),

7. 5883098 - Piperazine derivatives (1999-03-16),

8. 5670505 - Piperazine derivatives (1997-09-23),

9. 5661159 - Quinolylbenzofuran derivatives as leukotriene antagonists (1997-08-26),

10. 5296495 - Thiazolylbenzofuran derivatives and pharmaceutical composition (1994-03-22),

11. 5017703 - Indolylpiperidine compounds, processes for the preparation thereof and (1991-05-21),

12. 4935432 - Indolylpiperidine compounds, processes for the preparation thereof and (1990-06-19),

13. 4921887 - Thiazole compounds and pharmaceutical composition comprising the same (1990-05-01),

Title: **Innovative Contributions of Inventor Shinji Shigenaga**

Introduction

Shinji Shigenaga is an accomplished inventor based in Kobe, Japan, recognized for his significant contributions to the field of pharmaceuticals. With a total of 13 patents to his name, he has focused on making advancements that aid in the treatment of various medical conditions, particularly those related to tachykinin-mediated diseases.

Latest Patents

Among his latest innovations, Shigenaga has developed piperazine derivatives. This invention pertains to piperazine derivatives of a specific formula, which are important for their therapeutic applications. These derivatives can be utilized in formulating pharmaceutical compositions aimed at treating or preventing tachykinin-mediated diseases in humans and animals. Another notable patent involves aroyl-piperazine derivatives, which were designed as tachykinin antagonists, further enhancing the medicinal value of piperazine derivatives in addressing critical health issues.

Career Highlights

Shigenaga's career includes key roles in notable pharmaceutical companies. He has worked with Fujisawa Pharmaceutical Company, Ltd. and Astellas Pharma GmbH, where he contributed to the development of innovative treatments and technologies. His background in these reputable firms has allowed him to refine his expertise in medicinal chemistry and drug design.

Collaborations

Throughout his career, Shigenaga has collaborated with esteemed colleagues, including Masaaki Matsuo and Hiroshi Matsuda. These partnerships have fostered a creative and innovative environment that further propels his research and development endeavors in the pharmaceutical sector.

Conclusion

Shinji Shigenaga's innovations and patents make him a significant figure in the pharmaceutical industry. His work on piperazine derivatives plays an essential role in the ongoing efforts to discover effective treatments for challenging medical conditions. As he continues to contribute to advancements in medicinal science, the impact of his inventions will surely be felt in healthcare both in Japan and globally.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.